Shanghai Zj Bio-Tech's Ebola Test Kit Gains WHO Emergency Use Listing

Stock News
Jul 06

Shanghai Zj Bio-Tech Co.,Ltd. (ASX: 688317) has announced that its Ebola virus nucleic acid detection kit (using fluorescent PCR methodology) has been included in the World Health Organization's Emergency Use List (EUL).

The company received formal notification from the WHO, with the listing effective from July 2, 2026.

This specific product is designed to detect the Bundibugyo species of the Ebola virus.

Securing a place on the WHO EUL signifies the organization's validation and approval of the company's product.

This listing provides a procurement reference for WHO member states and other potential buyers, which is expected to facilitate the promotion and sales of the company's Ebola-related products in relevant overseas markets.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10